Centro Studi GISED


Go to content
Change language  EN IT

Psonet

What we do

Psonet

Centro Studi GISED has established Psonet, an international registry of systematic treatments for psoriasis in Europe, with the aim of obtaining safety and effectiveness data. A special focus is on the so-called "biologicals", i.e., drugs obtained by molecular biology techniques, such as etanercept, infliximab, adalimumab, ustekinumab and others. Uncertainties still exist about the long term safety and efficacy profile of these new drugs.

Back to research project


Last update nov 28 2016  -  Centro Studi GISED  P.I. 02274270988 | Terms of use    Privacy    Credits

Back to content | Back to main menu
Facebook Twitter Google+ LinkedIn Email